2004
DOI: 10.3184/0308234041209248
|View full text |Cite
|
Sign up to set email alerts
|

Designer ligands. Part 12.1 Synthesis and evaluation of novel palladium(II)–selective ligand systems

Abstract: The discovery of the anti-tumour platinum complexes, cisplatin 2 and carboplatin 3 has highlighted the potential of platinum-selective ligands in medicine -not only as anti-cancer agents, but also as "rescue agents" to remove the nephrotoxic platinum from the body. 4 Apparently, platinum is complexed by sulfur-rich proteins and enzymes in the kidney, and various sulfur-containing amide ligands have been developed to remove platinum from such biomolecules. 4 Separation of the valuable platinum group metals (PGM… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2011
2011
2022
2022

Publication Types

Select...
3

Relationship

1
2

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 18 publications
0
2
0
Order By: Relevance
“…This may rightly be deemed a daunting task. Nonetheless, MIP‐based catalytic systems and the use of MIPs in synthesis continue to evolve . Recent reports of several systems with significant catalytic power bodes well for the continued development in this sector.…”
Section: Applicationsmentioning
confidence: 99%
“…This may rightly be deemed a daunting task. Nonetheless, MIP‐based catalytic systems and the use of MIPs in synthesis continue to evolve . Recent reports of several systems with significant catalytic power bodes well for the continued development in this sector.…”
Section: Applicationsmentioning
confidence: 99%
“…Preliminary solvent extraction studies 24 using some of these and other related ligands indicated, in general, significant selectivity for palladium(II) over copper(II), nickel(II) and cobalt(II) and, in subsequent studies, 25 attention was given to the application of MIP technology in the construction of PGMselective MIPs (Scheme 4).…”
Section: Pgm-selective Ligands and Mipsmentioning
confidence: 99%